ClinicalTrials.Veeva

Menu

Invasive Hemodynamic Response to Transcatheter Edge-to-Edge Mitral Valve Repair

Mayo Clinic logo

Mayo Clinic

Status

Completed

Conditions

Mitral Regurgitation

Study type

Observational

Funder types

Other

Identifiers

NCT04200378
19-004449

Details and patient eligibility

About

Studying the effects of Trans-catheter Mitral Valve Repair (TMVr) on the hemodynamics and biomarkers in patients with severe mitral valve regurgitation.

Enrollment

22 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adults (age ≥ 18 years) with severe, symptomatic primary mitral regurgitation identified by Doppler transthoracic echocardiogram
  • Heart team (cardiologist and cardiac surgeon) agree that patient would be eligible for TMVR with Transcatheter edge to edge repair device.
  • TMVR procedure will be performed in the cardiac catheterization laboratory for hemodynamic data recording

Exclusion criteria

  • Women who are pregnant or believe they could be pregnant

Trial design

22 participants in 1 patient group

Subjects undergoing TMVr
Description:
Subjects with severe, symptomatic primary mitral regurgitation (MR) scheduled to undergo a transcatheter mitral valve repair (TMVr) as standard of care will have intra-op baseline and post repair blood draws. Pre-procedure and post-procedure transthoracic echocardiograms (TTE) will assess the hemodynamic implications of the repair.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems